Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.00)
# 1,797
Out of 5,096 analysts
1081
Total ratings
37.3%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Reiterated: Buy | $12 | $8.39 | +43.03% | 2 | Nov 2, 2026 | |
| PDSB PDS Biotechnology | Reiterated: Buy | $3 → $4 | $1.37 | +191.97% | 17 | Oct 29, 2026 | |
| INKT MiNK Therapeutics | Reiterated: Buy | $43 → $50 | $11.04 | +352.90% | 6 | Oct 21, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $45 → $29 | $13.35 | +117.23% | 7 | Oct 20, 2026 | |
| AGEN Agenus | Reiterated: Buy | $14 | $6.53 | +114.40% | 83 | Sep 24, 2026 | |
| ELTX Elicio Therapeutics | Reiterated: Buy | $27 → $8 | $1.59 | +403.14% | 2 | Sep 24, 2026 | |
| LCTX Lineage Cell Therapeutics | Reiterated: Buy | $4 | $1.01 | +296.04% | 18 | Sep 24, 2026 | |
| CUE Cue Biopharma | Initiated Coverage: Buy | $83 | $19.42 | +327.39% | 1 | Sep 18, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $26 → $30 | $9.74 | +208.01% | 2 | Sep 4, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $45 | $13.56 | +231.86% | 2 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15.37 | $1.47 | +945.73% | 1 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $18.86 | +85.58% | 26 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $2.33 | +372.10% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $3.49 | +473.07% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $28.20 | +112.77% | 30 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $28.99 | +51.78% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $4.59 | +205.01% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 → $31 | $13.63 | +127.44% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $146 | $62.03 | +135.37% | 24 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $170 | $129.53 | +31.24% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $117 → $155 | $127.51 | +21.56% | 4 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $9.53 | +88.88% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $4.79 | +150.52% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $9.49 | +131.82% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $150 | $36.95 | +305.95% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.92 | n/a | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $33 | $13.10 | n/a | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $55 | $59.95 | n/a | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.342 | n/a | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $2.02 | n/a | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $26.83 | n/a | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $59.57 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $422 → $460 | $431.16 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 → $2 | $0.4101 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $2 | $0.7096 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $50.81 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.93 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.415 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.67 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $1.87 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $3.35 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.561 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0006 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.13 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.38 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.44 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7675 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $120 | $12.84 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $10 | $15.85 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.00 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.84 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0003 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.33 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.81 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.40 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.11 | n/a | 1 | May 12, 2020 |
Exagen
Nov 2, 2026
Reiterated: Buy
Price Target: $12
Current: $8.39
Upside: +43.03%
PDS Biotechnology
Oct 29, 2026
Reiterated: Buy
Price Target: $3 → $4
Current: $1.37
Upside: +191.97%
MiNK Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $43 → $50
Current: $11.04
Upside: +352.90%
ArriVent BioPharma
Oct 20, 2026
Reiterated: Buy
Price Target: $45 → $29
Current: $13.35
Upside: +117.23%
Agenus
Sep 24, 2026
Reiterated: Buy
Price Target: $14
Current: $6.53
Upside: +114.40%
Elicio Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $27 → $8
Current: $1.59
Upside: +403.14%
Lineage Cell Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $4
Current: $1.01
Upside: +296.04%
Cue Biopharma
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $19.42
Upside: +327.39%
Climb Bio
Sep 4, 2026
Reiterated: Buy
Price Target: $26 → $30
Current: $9.74
Upside: +208.01%
Ascentage Pharma Group International
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $13.56
Upside: +231.86%
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $15.37
Current: $1.47
Upside: +945.73%
Aug 25, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $18.86
Upside: +85.58%
Aug 17, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $2.33
Upside: +372.10%
Aug 13, 2026
Reiterated: Buy
Price Target: $22 → $20
Current: $3.49
Upside: +473.07%
Aug 10, 2026
Reiterated: Buy
Price Target: $60
Current: $28.20
Upside: +112.77%
Aug 10, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $28.99
Upside: +51.78%
Aug 7, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $4.59
Upside: +205.01%
Aug 7, 2026
Initiated Coverage: Buy
Price Target: $16 → $31
Current: $13.63
Upside: +127.44%
Jul 31, 2026
Reiterated: Buy
Price Target: $108 → $146
Current: $62.03
Upside: +135.37%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $129.53
Upside: +31.24%
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $127.51
Upside: +21.56%
Apr 9, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $9.53
Upside: +88.88%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $4.79
Upside: +150.52%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $9.49
Upside: +131.82%
Feb 23, 2026
Reiterated: Buy
Price Target: $105 → $150
Current: $36.95
Upside: +305.95%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $3.92
Upside: n/a
Oct 3, 2025
Reiterated: Buy
Price Target: $29 → $33
Current: $13.10
Upside: n/a
Sep 17, 2025
Reiterated: Buy
Price Target: $53 → $55
Current: $59.95
Upside: n/a
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $0.342
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $18
Current: $2.02
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $85
Current: $26.83
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $38
Current: $59.57
Upside: n/a
May 2, 2025
Reiterated: Buy
Price Target: $422 → $460
Current: $431.16
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $2.5 → $2
Current: $0.4101
Upside: n/a
Feb 6, 2025
Reiterated: Buy
Price Target: $1.5 → $2
Current: $0.7096
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $50.81
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $1.93
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.415
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.67
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $1.87
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $3.35
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.561
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.0006
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.38
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 15, 2022
Reiterated: Buy
Price Target: $6
Current: $1.44
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $0.7675
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $3 → $120
Current: $12.84
Upside: n/a
Mar 23, 2022
Reiterated: Buy
Price Target: $17 → $10
Current: $15.85
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $7.84
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $3.33
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $1.81
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.40
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $9.11
Upside: n/a